May the 20th 2020 - (10:20 AM PDT | 1:20 PM EDT | 6:20 PM BST | 7:20 PM CEST), Highly Sensitive Crystal Digital PCRTM Detection kit for SARS-CoV-2 by Romain Parillaud, PhD (Stilla Technologies) Speakers’s Bio Romain received his PhD in Neuro-Immunology at Paris VI University, using gene expression analysis on [...]
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China. A Franco‐Chinese collaboration to better detect the virus and monitor its mutations Paris, February 25th, 2020 Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high‐precision genetic analyses, just announced it [...]
Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones.
Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones. Paris, February 11th, 2020 Stilla Technologies announced today that it has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group [...]
February the 27th 2020 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Digital PCR Method Development for Accurate Quantification of Copy Number Variations by Alexandra Whale (LGC London) Speakers’s Bio Alexandra Whale is the Science Leader for Nucleic Acid Innovation within the Molecular and [...]
Paris, France, December 10 , 2019 Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution PARIS, December 10, 2019 — Stilla Technologies, the provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome [...]
Stilla technologies has been picked as the Spotlight of the month by Illumina Ventures November 2019, Article on Illuminaventures.com Get the PDF file Our investor Illumina Ventures has featured Stilla Technologies as their monthly spotlight portfolio company. Read more about the press release here.
November the 19th 2019 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines by Moritz Kueblbeck & Andrea Callegari (EMBL) Speakers’s Bio Moritz Kueblbeck is a research technician at European Molecular Biology Laboratory. He [...]
Beverly, Massachusetts, USA, October 10 , 2019 Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations To Under the Leadership of Life Science Veteran Ruth Szebries Named General Manager and Vice President of Commercial Operations, Americas to Drive Rapid Adoption of the Company’s Naica™ Crystal Digital PCR™ System BEVERLY, Mass., October 10, [...]
Join Stilla & Wageningen University for a free hands-on digital PCR workshop on Friday 18th of October 2019
October the 19th 2019, Stilla Technologies in collaboration with Wageningen University organize a Digital PCR Workshop with the Naica System Wageningen University & Research (Netherlands) Register by contacting email@example.com
Stilla’s webinar in collaboration with Nature & University of Ghent on Wednesday 25th of September 2019
September the 25th 2019 - (8 AM PDT | 11 AM EDT | 4 PM BST | 5 PM CEST), History of Digital PCR: (r)evolution in genetic testing & analysis by Dr. Wim Trypsteen (University of Ghent) Speaker’s Bio Dr. Wim Trypsteen is a postdoctoral researcher at Ghent University and co-coordinator of [...]